Relating to transcatheter stent-valves

Information

  • Patent Grant
  • 11957573
  • Patent Number
    11,957,573
  • Date Filed
    Tuesday, May 18, 2021
    3 years ago
  • Date Issued
    Tuesday, April 16, 2024
    7 months ago
Abstract
Some embodiments of the present disclosure provide a stent-valve for transcatheter implantation to replace a cardiac valve. In some embodiments, the stent valve being compressible to a compressed state for delivery, and expandable to an operative state for implantation. In some embodiments, the stent-valve comprises a stent, a plurality of leaflets for defining a prosthetic valve, an inner skirt, an outer skirt, and a paravalve seal for sealing against surrounding tissue. In some embodiments, the paravalve seal comprising material that swells in response to contact with blood or components thereof.
Description
RELATED APPLICATIONS

The present disclosure claims priority to European patent application no. EP 12 002 015.1 filed, Mar. 22, 2012, the entire disclosure of which is herein incorporated by reference.


FIELD OF THE DISCLOSURE

The present disclosure relates to the field of transcatheter stem-valves. In some embodiments, the stent-valve may be a cardiac valve, for example, an aortic valve.


BACKGROUND

Transcatheter valve implantation (for example, transcatheter aortic valve implantation (TAVI)) is an evolving technology for replacement valve therapy that (i) avoids the trauma of conventional open-chest surgery, and (ii) avoids the need for heart and lung bypass. In such a technique, a stent-valve is compressed and loaded into a delivery catheter. The delivery catheter is introduced to the desired site of implantation (for example at the heart) via a percutaneous route or via minimally invasive surgery. The stent-valve is deployed into the implantation position from or by the delivery catheter, and the delivery catheter is then withdrawn.


Despite the successes of transcatheter stent-valves, technological challenges remain. One such challenge is preventing leakage of blood around the stent-valve (so called para-valve leakage). The above stents form a friction fit with the native anatomy to anchor the stent-valve in position, and are round in cross-section. However, the native anatomy in which the stent is implanted is often off-round and is different for each person. Moreover, heavy calcification of the native anatomy may obstruct full deployment of any stent, and make the native anatomy even more irregular. It can sometimes be difficult to provide a perfectly sealing fit between the stent-valve and the surrounding anatomy.


In order to address para-valve leakage, it is known to incorporate an external skirt or cover as part of the stent-valve. For example, the skirt is made of compressible biocompatible material, such as pericardial tissue or PET. The thicker the material of the skirt, the more able the skirt is to occlude gaps and effect a seal. However, a disadvantage is that such skirts add to the bulk of the stent-valve. A thick skirt makes the stent-valve problematic to compress to a desirably small size for implantation.


It would be desirable to provide a technique for mitigating para-valve leakage without substantially hindering the compressibility of a stent-valve.


SUMMARY OF THE DISCLOSURE

In some embodiments of the present disclosure, a stent-valve for transcatheter delivery is provided, with the stent-valve comprising a stent supporting a plurality of valve leaflets.


In some embodiments, a seal for mitigating para-valve leakage (which may be referred herein throughout either as “seal” or “para-valve leakage seal”) is provided. The seal may be of flexible and/or compliant material.


In some embodiments, the seal is carried by at least one seal support. The seal support may be collapsible to a stowed condition in which the seal is relatively streamlined or compressed with respect to the stent when the stent is compressed. For example, in the stowed condition, the seal support may be generally coplanar with the body of the stent, or may be arranged compressed against the stent. The seal support may be deployable to a deployed condition in which the support holds or biases the seal to a deployed state with respect to the stent. The seal support may be self-deploying from the stowed condition to the deployed condition. For example, the seal support may be constrainable in the stowed condition by sheathing of the stent in a compressed state for delivery. The seal support may be self-deploying from the stored state when the effect of the constraining sheath is removed. The seal support may be of shape memory material, for example, nitinol.


Various forms and structure of seal support are envisaged. In some embodiments, the seal support may be integral with the stent (e.g. integrally formed as part of the stent). In other forms, the seal support may be distinct from the stent. Such a seal support may optionally be coupled to or captive on the stent.


The seal support may be configured to bear against the material of the seal without penetrating through the seal material. For example, the seal support may have a shape that distributes contact force. A function of the seal support may be to urge the seal outwardly without the seal support penetrating through the seal material or into a tissue surface against which the seal is desired.


In some embodiments, the seal support may comprise a biasing element that biases the seal to a deployed condition (for example). The seal support (e.g. biasing element) may comprise, for example, a cantilever element (or a plurality of cantilever elements). The cantilever elements may be capable of flexing independently of one another, in order to provide a high degree of local seal conformity against an irregular lumen or tissue surface. In some embodiments, each cantilever element is associated with a respective aperture of a lattice structure of the stent. The cantilever elements may, for example, have one end coupled (or integral) with the stent body, and an opposite or remote end that is free to deploy outwardly. The remote end may have a rounded or enlarged or pad tip to avoid having a sharp end that might otherwise risk penetrating through the seal material. The cantilever elements may extend generally in the same direction as each other (e.g. having the remote end directed to one end (such as the outflow end) of the stent-valve), or the cantilever elements may be arranged in two opposite directions (e.g. at least one pointing towards the outflow end, and at least another pointing towards the inflow end), or the cantilever elements may be arranged in a variety of different directions. In some embodiments, the seal support comprises a ring shape, or tubular shape, or annular member. The member may have an annular coil shape.


In some embodiments, the seal support comprises a member that can be stowed in a generally elongate or helical form, and which deploys to a radially expanded loop form.


In some embodiments, the seal support comprises a portion of the stent that everts from a stowed condition to a deployed condition. Eversion of the stent can provide radial expansion upon deployment without increasing significantly the diameter of the stent when compressed (de-everted). For example, an inflow end or portion of the stent may evert towards the outflow end.


In some embodiments, the stent carries a sealing skirt (or web). The seal support may bias the skirt (or portions thereof) radially outwardly to distend away from the body of the stent.


Additionally or alternatively to embodiments noted above for a seal support, a seal of the stent-valve may be configured to be responsive to direction of blood flow past the seal, relative to inflow and outflow ends of the stent-valve. The seal may be configured such that blood flow in a reverse direction (for outflow to inflow) biases the seal to a deployed state to obstruct such flow.


For example, in some embodiments, the seal may comprise at least one web defining one or more pockets. The one or more pockets may be configured to fill with blood (or blood components) in response to blood flow in the reverse direction, such that the pocket distends outwardly. Distention of the pocket can fill a gap between the stent-valve and the surrounding anatomy, to obstruct the reverse flow of blood past the pocket.


In some embodiments, the pocket may be defined or carried at a respective aperture of a lattice structure of the stent. The pocket may be defined at least partly by an outer skirt carried on an exterior of the stent. Additionally or alternatively, the pocket may be defined at least partly by an inner skirt carried on an interior of the stent.


Additionally or alternatively to the above embodiments, a seal may comprise a skirt at least a portion of which is captive with respect to the stent, and at least a further portion of which is free to deploy or float relative to the stent.


In some embodiments, the further portion may contact a surrounding tissue or lumen wall before the body of the stent is fully deployed. As part of the deployment procedure, the stent may be displaced or biased in a first axial direction to seat against native leaflets. The frictional contact of the skirt against the tissue may cause the further portion of the skirt to bunch or wrinkle in the axial direction during the displacement action. Such bunching or wrinkling may provide additional material to fill voids or gaps between the stent and the surrounding tissue.


Additionally or alternatively, in some embodiments, the further portion of the skirt may seal may be responsive to direction or paravalve blood flow or to pressure blood. The further portion may, for example, deploy outwardly to contact a surrounding tissue lumen wall. The further portion may form a generally channel shape in response to pressure of blood or flow of blood in the reverse direction. The channel shape may bias an outer portion of the skirt to seat against the surrounding tissue or lumen surface.


Additionally or alternatively to the above embodiments, a seal of the stent-valve may be embossed to present a non-smooth surface. For example, the embossing may be defined by one or more sutures. The one or more sutures may define a zig-zag pattern. The suture may define a generally continuous embossment to obstruct blood flow past the stent.


Additionally or alternatively to the above embodiments, a seal of the stent-valve may be generally oversized compared to the diameter of the stent. The seal may be bunched or pleated by connections (e.g. suturing) to the stent that causes bunching or pleating between the connections. The bunching/pleating may create additional compliant bulk of seal material able to fill voids or gaps between the stent-valve and the surrounding tissue or lumen surface. The positions of the connections may define bunching or pleating in directions in a pattern that obstructs leakage of blood.


Additionally or alternatively to the above embodiments, a seal of the stent-valve may be configured to be self-expanding or self-filling due to a physical property of the seal.


For example, in some embodiments, the seal may be of or comprise a foam, sponge or fibrous material. Such a material may self-expand resiliently when the stent deploys. Additionally or alternatively, such a material may absorb blood (and/or components thereof) within its pores or interstices in order to expand the material physically or add bulk.


In some embodiments, the seal may be generally flat and/or tubular in a stowed state, and may roll or curl into an annular bead or doughnut when in a deployed state. The seal may be self-biased to the deployed state, but be resiliently deformable to the stowed state during compression of the stent for loading into a delivery apparatus. Upon removal of a constraining effect of a sheath of the delivery apparatus, the seal may be configured to readopt the deployed state, in order to provide a radially enlarged seal around the stent.


in some embodiments, at least a portion of the stent comprises a lattice structure, and the stent-valve further comprises one or more seals deployable from or through apertures of the lattice. In one form, the seals comprise web portions of material that define pockets associated with respective apertures of the lattice. The web portions may be configured to distend outwardly from the respective apertures. For example, in some embodiments, the web portions define pockets open on or to one side such that a respective pocket fills with blood to distend outwardly from the aperture of the lattice. Additionally or alternatively, the lattice structure of the stent may comprise biasing elements for biasing the web portions (e.g. pockets) of material radially outwardly from the lattice structure.


In some embodiments, the stent carries a sealing skirt (or web). The stent may comprise biasing elements for biasing the skirt (or portions thereof) radially outwardly to distend away from the body of the stent. The sealing skirt may optionally be carried on the exterior of the stent. An inner skirt (or web) may optionally be carried on the interior of the stem (and optionally coupled directly to the leaflets). At least one of the skirts may be of fabric (e.g. PET). Additionally or alternatively, at least one of the skirts may be of biological tissue, for example, pericardium.


In some embodiments, a biasing element distinct from the stent may bias a seal outwardly. For example, the biasing element may be a ring element (e.g. closed ring or split ring), within an annular seal. The biasing element may be compressible with the stent to a radially compressed condition. The biasing element may expand (e.g. self-expand) towards a radially expanded state when the stent is deployed. The biasing element may be of shape memory material, e.g. nitinol.


Certain features, ideas and advantages of the embodiments taught by the present disclosure are identified above and/or in the appended claims, but these do not limit any embodiment or invention disclosed herein. Protection is claimed for any novel idea or feature described herein and/or illustrated in the drawings whether to not emphasis has been placed thereon.





BRIEF DESCRIPTION OF THE DRAWINGS

Non-limiting embodiments of the disclosure are illustrated in the accompanying drawings, in which:



FIG. 1 is a schematic drawing illustrating a stent-valve 10, according to some embodiments of the disclosure.



FIG. 2a is a front view of a seal arrangement with cantilevered seal supports, and FIG. 2b is a side view of FIG. 2a in a deployed configuration, each according to some embodiments of the disclosure.



FIG. 3 is a schematic view of a seal arrangement with an annular wire seal support according to some embodiments of the disclosure.



FIG. 4a is a schematic perspective view of an elongate seal support around the stent in a compressed state, and FIG. 4b is a schematic top view of the seal when in a deployed state, each according to some embodiments of the disclosure.



FIG. 5a is a schematic view of a seal arrangement in a sheathed non-everted state, FIG. 5b shows initial unsheathing of the seal arrangement of FIG. 5a to permit everting, and FIG. 5c shows the seal arrangement of FIG. 5a when unsheathed, each according to some embodiments of the disclosure.



FIG. 6 is a schematic side view of a further example of seal arrangement with flexible cantilever arms, according to some embodiments of the disclosure.



FIG. 7a is a schematic side view of a seal arrangement comprising a rollable cuff when in a deployed state, and FIG. 7b is a schematic view of the seal arrangement when in a stowed, sheathed state, each according to some embodiments of the disclosure.



FIG. 8 is a schematic side view of a seal arrangement comprising a porous material, according to some embodiments of the disclosure.



FIG. 9a is a schematic side view of a seal arrangement comprising a floating skirt, and FIG. 9b is a schematic side view of the effect of the seal arrangement of FIG. 9a when implanted, according to some embodiments of the disclosure.



FIG. 10 is a schematic illustration of an alternative arrangement of a floating skirt seal, according to some embodiments of the disclosure.



FIG. 11 is a schematic illustration of an alternative seal arrangement using a plated skirt, according to some embodiments of the disclosure.



FIG. 12 is a schematic illustration of an alternative seal arrangement using a folded skirt, according to some embodiments of the disclosure.



FIG. 13 is a schematic illustration of an alternative seal arrangement using distensible pockets, according to some embodiments of the disclosure.



FIG. 14 is a schematic drawing of an alternative sealing arrangement using swellable material, according to some embodiments of the disclosure.



FIG. 15 is a schematic drawing illustrating administration of a sealant around the stent-valve, according to some embodiments of the disclosure.



FIG. 16 is a schematic view of an alternative sealing arrangement using coagulation material, according to some embodiments of the disclosure.



FIG. 17 is a schematic view of an alternative sealing arrangement using material that elutes calcium locally, according to some embodiments of the disclosure.



FIG. 18 is a partial schematic view of optional details of a stent-valve of FIG. 1, according to some embodiments of the disclosure.



FIG. 19 is a schematic section of the paravalve seal of FIG. 18, according to some embodiments of the disclosure.





DETAILED DESCRIPTION

Referring to FIG. 1 (and FIG. 18), a cardiac stent-valve 10 is illustrated for transcatheter implantation. The stent-valve 10 may be cardiac stent-valve, for example, an aortic stent-valve, a mitral stent-valve, a pulmonary stent-valve or a tricuspid stent-valve, for implantation at the respective valve position in a human heart.


The stent-valve 10 may optionally comprise biological tissue (for example, pericardium (such as porcine pericardium and/or bovine pericardium) and/or natural cardiac valve leaflets (for example, natural porcine cardiac valve leaflets, optionally attached to a portion of natural cardiac wall tissue). The biological tissue may be fixed, for example, using glutaraldehyde.


The stent-valve 10 may be compressible to a radially compressed condition (not shown) for delivery using a delivery catheter, and be expandable to an expanded condition (as shown) at implantation. The stent-valve 10 may comprise a stem 12 carrying a plurality of leaflets defining a valve 14. Various geometries of stent 12 may be used in some embodiments, the stent 12 may include one of more of: a lower tubular or crown portion 16; an upper crown portion 18; a plurality of upstanding commissural supports 20; and a plurality of stabilization arches 22. In use, the lower portion 16 of the stent 12 may be configured to be deployed after the other regions of the stent 12 have first been at least partly deployed. For example, the arches 22, the supports 20 and the upper crown 18 may be deployed at least partly before the lower portion 16 (in that order, or in reverse order, or in a different order). At least once the upper crown 18 has been at least partly deployed, the stent 12 may be urged and/or displaced in the direction of arrow 24 to seat the upper crown 18 against native leaflets at the implantation site. Deploying the lower portion 16 last fixes the stent 12 in its final position.


At least the lower portion 16, and optionally a portion of the upper crown 18, may be formed by a lattice structure of the stent. The lattice structure may define apertures, for example, generally diamond-shaped apertures.


The native leaflets may generally overlap a portion 26 of the stent. The native valve annulus may overlap a portion 28 of the stent.


Optionally, the stem-valve 10 may further comprise an inner skirt 30 communicating with the leaflets 14 and carried on an interior of the stent 12. Additionally or alternatively, the stent-valve 10 may further comprise an outer skirt 32 carried on an exterior of the stent 12. When both skirts are provided, the skirts may partially overlap. The skirts may be offset such that one skirt (e.g. the outer skirt 32) extends further towards a lower extremity of the stent 12 than the other (e.g. inner skirt 30). Additionally or alternatively, one skirt (e.g. the inner skirt 30) extends further towards an upper extremity of the stent 12 than the other (e.g. outer skirt 32). The skirts may be of any suitable flexible and/or compliant material, for example, fabric (e.g. of PET), or of plastics film (e.g. of PET), or of biological tissue (e.g. of pericardium).


Optionally, at least the outer skirt 32 is positioned to leave the upper crown 18 substantially un-obscured by the outer skirt 32. Such an arrangement may assist good blood flow to the coronary arteries (for example, in the case of a stent-valve for the aortic valve).


In some embodiments, the lower portion 16 has an extremity formed with a substantially zig-zag shape. The zig-zag shape may comprise lower apexes 16a and upper apexes 16b. The upper apexes 16b may be masked in FIG. 1 by the superimposed presentation of both the front most and rearmost cells of the lattice structure. The zig-zag shape may be substantially continuous around the circumference of the stent 12. The outer skirt 32 may have a peripheral edge having a zig-zag shape that matches substantially the zig-zag shape of the extremity of the lower portion 16. Such an arrangement can avoid excessive material at the extremity, and thereby facilitate crimping of the stent-valve 10. At the same time, the outer skirt 32 covers (for example, complete) open cells of the lattice structure down to the stent extremity to reduce risk of blood leakage through the apertures of the cells. The outer skirt 32 can also provide a layer of material over the struts of the stent, thereby to cushion the engagement between the stent and the sensitive native heart tissue.


The valve 14 may comprise biological tissue, for example, pericardium (such as porcine pericardium or bovine pericardium) or natural cardiac valve leaflets (for example, natural porcine cardiac valve leaflets, optionally attached to a portion of natural cardiac wall tissue). Other biological or non-biological material could also be used for the valve 14, as desired.


The stent 12 may optionally be of a self-expanding type that is compressible to the compressed state for loading into a delivery catheter having a sheath for constraining the stent 12 in the compressed state for delivery to the site of implantation. In use, by removal of the constraining effect of the sheath, the stent 12 self-expands to or towards the expanded state. A self-expanding stent may, for example, me of shape-memory material, for example, shape-memory metal alloy, for example, nitinol. Alternatively, the stent 12 may be configured to be expanded by application of an expanding force from the delivery catheter, such as by using an expansion balloon.


There now follows a description of various seal configurations that may be used with the above-described stent-valve 10. The seal configurations may also be used with different stent shapes and configurations.



FIG. 2 illustrates a first example of seal support in the form of a plurality cantilever elements 40 mounted on or integral with the stent 12. Each cantilever element 40 may be associated with a respective aperture 42 of the lattice structure. Each cantilever element 40 may be bendable generally independently of the others. Each cantilever element 40 may be movable between a stowed condition, in which the cantilever element is generally co-planar with the portion of the stent 12 around the aperture 42 (or at least is compressed to lie directly or indirectly there against), and a deployed condition in which the cantilever element 40 is biased radially outwardly from the body (e.g. lower portion 16) of the stent 12 (FIG. 2b). The seal support urges a seal (e.g. the outer skirt 32) outwardly so as to fill gaps or voids between the stent-valve 10 and the surrounding lumen/tissue. The ability of the cantilever elements 40 to flex independently can provide a high degree of local conformity. Each cantilever element 40 may have a remote end 40a in the form of a rounded, or pad-like, or other non-damaging shape that can bear against the seal material to bias the seal radially outwardly, without penetrating through, or puncturing, the seal material.


The cantilever elements 40 may be arranged generally in the same orientation (e.g. with the remote ends 40a directed towards one end, e.g. the outlet end, of the stent 12), or distributed to be orientated in two opposite directions, or be distributed to be orientated in a variety of different directions.


The seal urged by the cantilever elements 40 may be generally continuous, or it may be discontinuous in the form of webs or pockets. The pockets may be arranged such that back-pressure of blood, or para-valvular blood flow in the reverse direction from outlet to inlet end of the stent 12, fills the pockets to cause the pockets further to distend, thereby enhancing the seal effect to obstruct such para-valvular flow. Further detail of such pockets is also described with reference to FIG. 13, and any of such features may also be used with the present example.


Referring to FIG. 3, a seal support 46 is illustrated in the form of an annular wire or ring that is oversize compared to the stent 10. The annular wire is compressible to a stowed state when the stent is compressed, and expands to a deployed state when unconstrained, to urge the seal 48 to a radially expanded state to form a seal against the surrounding tissue/lumen.


Referring to FIG. 4, a seal support 50 is illustrated in the form of an elongate member carrying a seal 52. The seal support is compressible to a stowed form (FIG. 4a) for example a helical shape around the stent 12 when in its compressed state. The seal support is expandable to a deployed state (FIG. 4b), for example, a radially expanded closed or semi-closed loop form in which the seal support presents the seal 52 in expanded form around the stent 12.


Referring to FIG. 5, a seal support 54 is illustrated in the form of an everting portion of the lower region 16 of the stent 12. The seal support 54 is movable between a stowed, non-everted configuration and a deployed, everted configuration. In a compressed form constrained by a sheath 56 (FIG. 5a), the lower portion of the stent including the seal support 54 is generally tubular (non-evened). As the sheath 56 is progressively removed axially (FIG. 5b), the seal support 56 is unsheathed. Unconstrained, the seal support 56 everts to its deployed state in which the seal is presented and/or biased radially outwardly from the stent body. Further unsheathing of the stent 12 or the lower portion 16 (FIG. 5c) permits the stent 12 to expand to its expanded state. The everted seal support 54 urges the seal into tight sealing contact with the surrounding tissue/lumen. The seal may be carried on the inners surface of the stent when compressed, and presented in an outward direction when everted.



FIG. 6 illustrates a seal support that is similar to both FIGS. 2 and 5. The seal support 58 comprises flexible cantilever elements at the lower portion 16 of the stent 12, similar to those of FIG. 2. The seal support 58 also resembles the everted state of the seal support 56 of FIG. 5. In the example of FIG. 6, the cantilever elements do not move between an everted and non-everted state. In the stowed state, the cantilever elements are generally flat against or within the structure of the stent 12 (similar to FIG. 2).



FIG. 7 illustrates a seal in the form of a rollable bead or cuff 60. The rollable cuff 60 may be self-biased or it may be supported by a seal support frame that tends to roll the cuff 60. In a stowed state (FIG. 7b), the cuff is unrolled to define a generally flat tubular form. The cuff may be constrained in the stowed state by a constraining sheath 62 of a delivery device. When unsheathed, the cuff 60 is free to move to its deployed state (FIG. 7a) in which the cuff 60 rolls up to define a cuff or bead shape. Such a seal provides a compliant bead of material to fill any gap between the stent 12 and the surrounding tissue/lumen.



FIG. 8 illustrates a seal 74 in the form of foam, or sponge or fibrous porous material. Such material is compressible when dry, because air is easily expelled from the pores and/or interstices of material when compressed. The seal 74 may therefore adopt a compressed state without increasing the bulk of the stent-valve 10 significantly. Once implanted, blood may penetrate and fill the pores and/or interstices of the seal material. The blood may become trapped in the pores and/or interstices, thereby creating a barrier to blood flow through the material. The blood may also cause distension of the seal material to further expand the seal outwardly and fill any gaps of voids around the stent-valve 10.



FIG. 9 illustrates a seal in the form of a flexible skirt 80. The skirt 80 depends, for example, from the junction between the upper crown 18 and the lower portion 16 of the stent 16, to at least partly overlap the lower portion 16. A first (e.g. upper) portion 82 of the skirt 80 is coupled to the stent 12, to hold the skirt 80 captive. For example, the first portion 82 may be sutured to the stent 12. A second (e.g. depending) portion 84 of the skirt 80 is generally unconstrained, and is free to float relative to the stent 12.


As illustrated in FIG. 9b (and explained above in relation to FIG. 1), the implantation procedure for the stent-valve 10 may involve displacing the stent-valve in the direction of arrow 24 to seat the upper crown 18 against native valve leaflets. The friction between the floating second portion 84 of the skirt 80, and the surrounding tissue/lumen may cause the second portion 84 to bunch or wrinkle axially, thus creating an excess of material that is able to seal any gap between the stent-valve 10 and the surrounding tissue/lumen.



FIG. 10 illustrates an alternative seal in the form of a flexible skirt 90. In contrast to the skirt of FIG. 9, the skirt 90 projects from the upper crown 18 towards the upper end of the stent 12. As indicated in phantom, under back pressure of blood, or reverse flow of blow around the stent-valve 10, the flexible skirt bears outwardly to seal against the surrounding tissue/lumen. The flexible skirt may form a channel shape section such that the back pressure of blood increases the sealing pressure against the surrounding tissue/lumen.



FIG. 11 illustrates an alternative seal in the form of an oversized flexible skirt 100 that is connected to the stent 12 at one or more positions to define pleating or bunching. The connections may be by suturing. The pleating or bunching creates additional compliant material able to fill yids of gaps between the stent 12 and the surrounding tissue/lumen.



FIG. 12 illustrates an alternative seal in the form of a skirt that is folded to define a cuff 102. The skirt material is flexible, but the fold creates a radiused bend providing a natural bulge. The bulge biases the seal material outwardly in order to fill voids or gaps between the stent 12 and the surrounding tissue/lumen.



FIG. 13 illustrates an alternative seal comprising a plurality of flexible pockets 110. Each pocket may be associated with a respective aperture 112 of a lattice structure of the stent, for example, the lower portion 16 and/or the upper crown 18. The pocket 110 may be defined by a flexible web of material. One wall of the pocket may be define by a portion of the outer skirt. Another wall of the pocket may be defined by a portion of the inner skirt. The pocket may be open on one side facing towards the outlet end of the stent, and closed in the opposite direction. In a stowed state, the pocket may collapse or fold substantially flat so as not to increase the bulk of the stent-valve. Once deployed, the pocket may open either under the influence of natural resilience, or under the influence of blood back pressure entering the mouth of the pocket. The back pressure causes the pocket to distend outwardly against surrounding tissue/lumen, and thereby further obstructing leakage of blood around the outside of the stent-valve 10.



FIG. 14 illustrates an alternative seal arrangement comprising material 120 that swells in response to contact with blood. The swelling characteristics increase the bulk of the seal, enabling the seal to distend to fill any gaps between the stent-valve 10 and the surrounding tissue/lumen. Example swellable materials include a hydrogel and/or a liquid swellable polymer, and/or a so called superabsorbent material. The material may, for example, be carried by, or impregnated or otherwise embodied within the outer skirt. For example, the skirt may be of fabric comprising fibers of the swellable material. The material may be captive within a containing chamber, for example a flexible and/or distensible pouch or cuff. The combination of inner and outer skirts, with one comprising swellable material, can provide an especially effective seal arrangement. Further background information of use of, for example, a hydrogel for stent-valves may be found in US 2005/137688.


The seal of FIG. 14 is also illustrated in other embodiments of FIGS. 18 and 19. The swellable material is denoted by numeral 44, the containing chamber 42, together defining the paravalve seal 40 carried by, or comprised within, the outer skirt 32.



FIG. 15 illustrates an alternative seal arrangement in which a sealant 122 is dispensed from the delivery catheter 124 (or from a further delivery catheter inserted after implantation), in order to seal around the periphery of the stent valve 10. For example, the sealant is dispensed on the outflow side of the stent-valve to seal any gaps between the upper crown and the native leaflets.



FIG. 16 illustrates an alternative seal arrangement comprising material 124 that provides hemostatic and/or coagulant effects in response to contact with blood. The material 124 may, for example, be carried by, or impregnated or otherwise embodied within the outer skirt. The material may be captive within a containing chamber, for example a flexible and/or distensible pouch or cuff. The combination of inner and outer skirts, with one comprising such material, can provide an especially effective seal arrangement.



FIG. 17 illustrates an alternative seal arrangement comprising material 126 that elutes calcium locally. The calcium may deposit directly or indirectly against the surrounding tissue/lumen such that any gaps can be occluded. The material 126 may, for example, be carried by, or impregnated or otherwise embodied within the outer skirt. The material may be captive within a containing chamber, for example a flexible and/or distensible pouch or cuff. The combination of inner and outer skirts, with one comprising such material, can provide an especially effective seal arrangement.


Although the seal arrangements have been described as alternatives, it is envisaged that any two or more of the seal arrangements may be combined for synergistic effect.


Any and all references to publications or other documents, including but not limited to, patents, patent applications, articles, webpages, books, etc., presented in the present application, are herein incorporated by reference in their entirety.


Although a few variations of the disclosed subject matter have been described in detail above, other modifications are possible. For example, any logic flow depicted in the accompanying figures and/or described herein does not require the particular order shown, or sequential order, to achieve desirable results. Other implementations may be within the scope of at least some of the following exemplary claims.


Example embodiments of the devices, systems and methods have been described herein. As noted elsewhere, these embodiments have been described for illustrative purposes only and are not limiting. Other embodiments are possible and are covered by the disclosure, which will be apparent from the teachings contained herein. Thus, the breadth and scope of the disclosure should not be limited by any of the above-described embodiments but should be defined only in accordance with claims supported by the present disclosure and their equivalents. Moreover, embodiments of the subject disclosure may include methods, systems and devices which may further include any and all elements from any other disclosed methods, systems, and devices, including any and all elements corresponding to stent-valves, and/or seals for stent-valves. In other words, elements from one or another disclosed embodiments may be interchangeable with elements from other disclosed embodiments. In addition, one or more features/elements of disclosed embodiments may be removed and still result in patentable subject matter (and thus, resulting in yet more embodiments of the subject disclosure).

Claims
  • 1. A stent-valve for transcatheter implantation to replace a cardiac valve, the stent-valve being compressible to a compressed state for delivery, and expandable to an operative state for implantation, the stent-valve comprising a stent, a plurality of leaflets for defining a prosthetic valve, a paravalve seal for sealing against surrounding tissue, and a seal support, wherein the paravalve seal comprises a skirt, the skirt including an inner skirt disposed on an interior of the stent and an outer skirt disposed on an exterior of the stent, the inner skirt and outer skirt together defining a one or more pocket, wherein the outer skirt or portions thereof is biased radially outwardly to distend away from the body of the stent such that each pocket defines an open mouth facing towards an outlet end of the stent, and an end of the pocket opposite the mouth is closed, wherein the seal support comprises a plurality of cantilever elements fixed directly to the stent and biased radially outward from the stent and holding the mouth of the pocket open and radially outward away from the body of the stent, wherein the seal is configured such that blood flow in a reverse direction biases the seal pocket in an open state to obstruct such flow.
  • 2. The stent-valve of claim 1, wherein each of the cantilever elements comprises a single strut or plural struts.
  • 3. The stent-valve of claim 2, wherein each of the cantilever elements is associated with a respective aperture of a lattice structure of the stent.
  • 4. The stent-valve of claim 3, wherein each of the cantilever elements has one end coupled directly to or integral with the stent body, and an opposite or remote end that is free to deploy outwardly.
  • 5. The stent-valve of claim 4, wherein the cantilever elements extend generally in the same direction as each other, or, where the cantilever elements are arranged in two opposite directions or in a variety of different directions.
  • 6. The stent-valve of claim 5, wherein the pocket is pushed outwardly by the cantilever elements.
  • 7. The stent-valve of claim 6, wherein the pocket is positioned such that back-pressure of blood, or para-valvular blood flow in the reverse direction from outlet to inlet end of the stent, fills the pocket to cause the pocket to further to distend, thereby enhancing the seal effect to obstruct para-valvular flow.
  • 8. The stent-valve of claim 7, wherein the seal support at least partly biases the skirt outwardly into engagement with surrounding tissue.
  • 9. The stent-valve of claim 1, wherein the seal support is defined by an upper crown of the stent.
  • 10. The stent-valve of claim 9, wherein the skirt is attached to the upper crown.
  • 11. The stent-valve of claim 10, wherein the cantilever elements are independently deformable for conforming to local anatomy.
  • 12. The stent-valve of claim 1, wherein one wall of each pocket is defined by a portion of the outer skirt and another wall of each pocket is defined by a portion of the inner skirt.
  • 13. The stent-valve of claim 1, wherein each pocket is associated with a respective aperture of a lattice structure of the stent.
  • 14. The stent-valve of claim 1, wherein a portion of the stent extends beyond the pocket towards both an inflow end and an outflow end of the stent-valve.
  • 15. A stent-valve for transcatheter implantation to replace a cardiac valve, the stent-valve being compressible to a compressed state for delivery and expandable to an operative state for implantation, the stent-valve comprising: a stent;a plurality of leaflets for defining a prosthetic valve; anda seal for sealing against surrounding tissue, the seal including an inner skirt disposed on an interior of the stent, an outer skirt disposed on an exterior of the stent, and a seal support, the inner skirt and outer skirt together defining one or more pocket, wherein a portion of the stent extends beyond the pocket towards both an inflow end and an outflow end of the stent-valve, wherein a portion of the outer skirt defining each pocket is biased radially outwardly to distend away from the body of the stent such that each pocket defines an open mouth facing towards the outflow end of the stent, and an end of the pocket opposite the mouth in the direction towards the inflow end of the stent is closed, wherein the seal support comprises a plurality of cantilever elements fixed directly to the stent and biased radially outward from the stent and holding the mouth of the pocket open and radially outward away from the body of the stent, wherein the seal is configured such that blood flow in a reverse direction from the outlet to the inlet biases the seal pocket to a deployed in an open state to obstruct such flow.
  • 16. The stent-valve of claim 15, wherein one wall of each pocket is defined by a portion of the outer skirt and another wall of each pocket is defined by a portion of the inner skirt.
  • 17. The stent-valve of claim 15, wherein each pocket is associated with a respective aperture of a lattice structure of the stent.
Priority Claims (1)
Number Date Country Kind
12002015 Mar 2012 EP regional
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of priority of U.S. application Ser. No. 15/344,135 filed Nov. 4, 2016, which is a continuation of U.S. application Ser. No. 14/879,482 filed Oct. 9, 2015, which is a continuation of U.S. application Ser. No. 13/839,357 filed Mar. 15, 2013, the entirety of these applications of which are hereby incorporated by reference.

US Referenced Citations (264)
Number Name Date Kind
3755823 Hancock Sep 1973 A
4106129 Carpentier et al. Aug 1978 A
4470157 Love Sep 1984 A
5078720 Burton et al. Jan 1992 A
5163955 Love et al. Nov 1992 A
5192301 Kamiya et al. Mar 1993 A
5344442 Deac Sep 1994 A
5354330 Hanson et al. Oct 1994 A
5411552 Andersen et al. May 1995 A
5480424 Cox Jan 1996 A
5499995 Teirstein Mar 1996 A
5500015 Deac Mar 1996 A
5540712 Kleshinski et al. Jul 1996 A
5571174 Love et al. Nov 1996 A
5609626 Quijano et al. Mar 1997 A
5653749 Love et al. Aug 1997 A
5662703 Yurek et al. Sep 1997 A
5713950 Cox Feb 1998 A
5713951 Garrison et al. Feb 1998 A
5718725 Sterman et al. Feb 1998 A
5769882 Fogarty et al. Jun 1998 A
5797960 Stevens et al. Aug 1998 A
5807327 Green et al. Sep 1998 A
5817126 Imran Oct 1998 A
5823956 Roth et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5840081 Andersen et al. Nov 1998 A
5855600 Alt Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5861028 Angell Jan 1999 A
5924424 Stevens et al. Jul 1999 A
5938697 Killion et al. Aug 1999 A
5957949 Leonhardt et al. Sep 1999 A
5976174 Ruiz Nov 1999 A
5980533 Holman Nov 1999 A
6029671 Stevens et al. Feb 2000 A
6083257 Taylor et al. Jul 2000 A
6102944 Huynh et al. Aug 2000 A
6110201 Quijano et al. Aug 2000 A
6168614 Andersen et al. Jan 2001 B1
6171335 Wheatley et al. Jan 2001 B1
6183481 Lee et al. Feb 2001 B1
6196230 Hall et al. Mar 2001 B1
6214036 Letendre et al. Apr 2001 B1
6254564 Wilk et al. Jul 2001 B1
6287334 Moll et al. Sep 2001 B1
6287339 Vazquez et al. Sep 2001 B1
6331189 Wolinsky et al. Dec 2001 B1
6350278 Lenker et al. Feb 2002 B1
6379383 Palmaz et al. Apr 2002 B1
6401720 Tu et al. Jun 2002 B1
6406493 Tu et al. Jun 2002 B1
6409759 Peredo Jun 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6530952 Vesely Mar 2003 B2
6533807 Wolinsky et al. Mar 2003 B2
6537310 Palmaz et al. Mar 2003 B1
6562069 Cai et al. May 2003 B2
6569196 Vesely May 2003 B1
6572652 Shaknovich Jun 2003 B2
6582462 Andersen et al. Jun 2003 B1
6589279 Anderson et al. Jul 2003 B1
6613079 Wolinsky et al. Sep 2003 B1
6635085 Caffey et al. Oct 2003 B1
6652555 VanTassel et al. Nov 2003 B1
6682558 Tu et al. Jan 2004 B2
6682559 Myers et al. Jan 2004 B2
6695865 Boyle et al. Feb 2004 B2
6719787 Cox Apr 2004 B2
6729356 Baker et al. May 2004 B1
6730118 Spenser et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6736827 McAndrew et al. May 2004 B1
6755855 Yurek et al. Jun 2004 B2
6767362 Schreck Jul 2004 B2
6790229 Berreklouw Sep 2004 B1
6805711 Quijano et al. Oct 2004 B2
6830584 Seguin Dec 2004 B1
6830585 Artof et al. Dec 2004 B1
6830586 Quijano et al. Dec 2004 B2
6849085 Marton Feb 2005 B2
6875231 Anduiza et al. Apr 2005 B2
6893460 Spenser et al. May 2005 B2
6908481 Cribier Jun 2005 B2
6936066 Palmaz et al. Aug 2005 B2
6942682 Vrba et al. Sep 2005 B2
7018406 Seguin et al. Mar 2006 B2
7025773 Gittings et al. Apr 2006 B2
7025780 Gabbay Apr 2006 B2
7041132 Quijano et al. May 2006 B2
7044966 Svanidze et al. May 2006 B2
7101396 Artof et al. Sep 2006 B2
7141064 Scott et al. Nov 2006 B2
7179290 Cao Feb 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7217287 Wilson et al. May 2007 B2
7252682 Seguin Aug 2007 B2
7276078 Spenser et al. Oct 2007 B2
7285130 Austin Oct 2007 B2
7316712 Peredo Jan 2008 B2
7318278 Zhang et al. Jan 2008 B2
7320704 Lashinski et al. Jan 2008 B2
7320705 Quintessenza Jan 2008 B2
7329278 Seguin et al. Feb 2008 B2
7329279 Haug et al. Feb 2008 B2
7331991 Kheradvar et al. Feb 2008 B2
7331993 White Feb 2008 B2
7338484 Schoon et al. Mar 2008 B2
7361189 Case et al. Apr 2008 B2
7371258 Woo et al. May 2008 B2
7374571 Pease et al. May 2008 B2
7377938 Sarac et al. May 2008 B2
7381218 Schreck Jun 2008 B2
7381219 Salahieh et al. Jun 2008 B2
7393358 Malewicz Jul 2008 B2
7393360 Spenser et al. Jul 2008 B2
7399315 Iobbi Jul 2008 B2
7402171 Osborne et al. Jul 2008 B2
7410499 Bicer Aug 2008 B2
7416530 Turner et al. Aug 2008 B2
7422603 Lane Sep 2008 B2
7431733 Knight Oct 2008 B2
7435257 Lashinski et al. Oct 2008 B2
7445632 McGuckin, Jr. et al. Nov 2008 B2
7455689 Johnson Nov 2008 B2
7470284 Lambrecht et al. Dec 2008 B2
7470285 Nugent et al. Dec 2008 B2
7473275 Marquez Jan 2009 B2
7481838 Carpentier et al. Jan 2009 B2
7500989 Solem et al. Mar 2009 B2
7503929 Johnson et al. Mar 2009 B2
7503930 Sharkawy et al. Mar 2009 B2
7510572 Gabbay Mar 2009 B2
7510575 Spenser et al. Mar 2009 B2
7513909 Lane et al. Apr 2009 B2
7534261 Friedman May 2009 B2
7556646 Yang et al. Jul 2009 B2
7578828 Gittings et al. Aug 2009 B2
7585321 Cribier Sep 2009 B2
7591848 Allen Sep 2009 B2
7618446 Andersen et al. Nov 2009 B2
7625403 Krivoruchko Dec 2009 B2
7632296 Malewicz Dec 2009 B2
7682390 Seguin Mar 2010 B2
7780726 Seguin Aug 2010 B2
7846203 Cribier Dec 2010 B2
7846204 Letac et al. Dec 2010 B2
7896915 Guyenot et al. Mar 2011 B2
7914575 Guyenot et al. Mar 2011 B2
7947075 Goetz et al. May 2011 B2
7959672 Salahieh et al. Jun 2011 B2
8002825 Letac et al. Aug 2011 B2
8052749 Salahieh et al. Nov 2011 B2
8057540 Letac et al. Nov 2011 B2
8092518 Schreck Jan 2012 B2
8092520 Quadri Jan 2012 B2
8403983 Quadri Mar 2013 B2
8603159 Seguin et al. Dec 2013 B2
8628571 Hacohen et al. Jan 2014 B1
8926690 Kovalsky Jan 2015 B2
8992604 Gross Mar 2015 B2
9351831 Braido et al. May 2016 B2
10245143 Gross Apr 2019 B2
20010007956 Letac et al. Jul 2001 A1
20010039450 Pavcnik et al. Nov 2001 A1
20020177894 Acosta et al. Nov 2002 A1
20030023300 Bailey et al. Jan 2003 A1
20030028213 Thill et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030042186 Boyle Mar 2003 A1
20030109924 Cribier Jun 2003 A1
20030114913 Spenser et al. Jun 2003 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040044361 Frazier et al. Mar 2004 A1
20040044400 Cheng et al. Mar 2004 A1
20040093060 Seguin et al. May 2004 A1
20040093063 Wright et al. May 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040186563 Lobbi Sep 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040254594 Alfaro Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20050043759 Chanduszko Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050070794 Deal et al. Mar 2005 A1
20050070957 Das Mar 2005 A1
20050113910 Paniagua et al. May 2005 A1
20050137681 Shoemaker et al. Jun 2005 A1
20050137688 Salahieh Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050182483 Osborne et al. Aug 2005 A1
20050267523 Devellian et al. Dec 2005 A1
20050283231 Haug et al. Dec 2005 A1
20050288706 Widomski et al. Dec 2005 A1
20060004442 Spenser Jan 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060122692 Gilad et al. Jun 2006 A1
20060161248 Case et al. Jul 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20070060998 Butterwick et al. Mar 2007 A1
20070061002 Paul et al. Mar 2007 A1
20070073387 Forster et al. Mar 2007 A1
20070118210 Pinchuk May 2007 A1
20070179600 Vardi Aug 2007 A1
20070198097 Zegdi Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070239265 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070244546 Francis Oct 2007 A1
20070282436 Pinchuk Dec 2007 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080077234 Styrc Mar 2008 A1
20080125859 Salahieh et al. May 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080161909 Kheradvar et al. Jul 2008 A1
20080177381 Navia et al. Jul 2008 A1
20080195199 Kheradvar et al. Aug 2008 A1
20080208327 Rowe Aug 2008 A1
20080228263 Ryan Sep 2008 A1
20080234814 Salahieh et al. Sep 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080269878 Iobbi Oct 2008 A1
20080275550 Kheradvar et al. Nov 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090164006 Seguin et al. Jun 2009 A1
20090171432 Von Segesser et al. Jul 2009 A1
20090171447 Von Segesser et al. Jul 2009 A1
20090276040 Rowe et al. Nov 2009 A1
20090287299 Tabor et al. Nov 2009 A1
20100082094 Quadri Apr 2010 A1
20100168839 Braido et al. Jul 2010 A1
20110040374 Goetz et al. Feb 2011 A1
20110098802 Braido et al. Apr 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110224780 Tabor et al. Sep 2011 A1
20110264196 Savage et al. Oct 2011 A1
20120101571 Thambar et al. Apr 2012 A1
20120101572 Kovalsky et al. Apr 2012 A1
20120116496 Chuter et al. May 2012 A1
20120123529 Levi et al. May 2012 A1
20120172982 Stacchino et al. Jul 2012 A1
20120179244 Schankereli Jul 2012 A1
20120303116 Gorman et al. Nov 2012 A1
20130190857 Mitra Jul 2013 A1
20130190861 Chau et al. Jul 2013 A1
20130310928 Morriss Nov 2013 A1
20140142694 Tabor May 2014 A1
20140194981 Menk et al. Jul 2014 A1
20140243966 Garde Aug 2014 A1
20140277419 Garde Sep 2014 A1
20140277423 Alkhatib Sep 2014 A1
20140350668 Delaloye et al. Nov 2014 A1
20170112621 Salahieh Apr 2017 A1
20180263765 Flaction Sep 2018 A1
Foreign Referenced Citations (81)
Number Date Country
20063288896 Jun 2007 AU
2007294199 Mar 2008 AU
2009200985 Apr 2009 AU
2634358 Jun 2007 CA
2657839 Mar 2008 CA
2659690 Mar 2008 CA
20003874 May 2000 DE
19857887 Jul 2000 DE
102005003632 Aug 2006 DE
202007005491 Jun 2007 DE
0592410 Apr 1994 EP
0657147 Jun 1995 EP
0696447 Feb 1996 EP
0943302 Sep 1999 EP
1093771 Apr 2001 EP
12511797 Oct 2002 EP
1262201 Dec 2002 EP
1264582 Dec 2002 EP
1267753 Jan 2003 EP
1598031 Nov 2005 EP
1968491 Sep 2008 EP
2033593 Mar 2009 EP
2047824 Apr 2009 EP
2059192 May 2009 EP
2074964 Jul 2009 EP
3616652 Mar 2013 EP
3616652 Mar 2020 EP
2815844 May 2002 FR
2874812 Mar 2006 FR
2932376 Dec 2009 FR
9117720 Nov 1991 WO
9829057 Jul 1998 WO
0028922 May 2000 WO
0047139 Aug 2000 WO
0053122 Sep 2000 WO
0149213 Jul 2001 WO
0156500 Aug 2001 WO
0156505 Aug 2001 WO
0162189 Aug 2001 WO
0176510 Oct 2001 WO
02067782 Sep 2002 WO
02076349 Oct 2002 WO
03003949 Jan 2003 WO
03047468 Jun 2003 WO
03063729 Aug 2003 WO
2005070343 Aug 2005 WO
2005102015 Nov 2005 WO
2006058163 Jun 2006 WO
2006068944 Jun 2006 WO
2006076890 Jul 2006 WO
2006083763 Aug 2006 WO
2006086135 Aug 2006 WO
2006086736 Aug 2006 WO
2006127765 Nov 2006 WO
2007009117 Jan 2007 WO
2007071436 Jun 2007 WO
2007071436 Jun 2007 WO
2008028569 Mar 2008 WO
2008040555 Apr 2008 WO
2008070442 Jun 2008 WO
2009024859 Feb 2009 WO
2009053497 Apr 2009 WO
2009091509 Jul 2009 WO
2010008548 Jan 2010 WO
2010045238 Apr 2010 WO
2010045297 Apr 2010 WO
2010049160 May 2010 WO
2010083558 Jul 2010 WO
2011051043 May 2011 WO
2011057087 May 2011 WO
2011133787 Oct 2011 WO
2012048035 Apr 2012 WO
2012177942 Dec 2012 WO
2013033791 Mar 2013 WO
2013086132 Jun 2013 WO
2013134214 Sep 2013 WO
2014072439 May 2014 WO
2014121042 Aug 2014 WO
2014139545 Sep 2014 WO
2014158710 Oct 2014 WO
2014163706 Oct 2014 WO
Related Publications (1)
Number Date Country
20210322159 A1 Oct 2021 US
Continuations (3)
Number Date Country
Parent 15344135 Nov 2016 US
Child 17323452 US
Parent 14879482 Oct 2015 US
Child 15344135 US
Parent 13839357 Mar 2013 US
Child 14879482 US